Objectives Little is routinely disclosed about the costs of the pivotal clinical trials that provide the key scientific evidence of the treatment benefits of new therapeutic agents. We expand our ...

Abstract: It is already a consensus that intra-class variations will decline the performance of biometric systems. Many studies have explained how intra-class variations affect the biometric systems, ...